acetaminophen has been researched along with B-Cell Chronic Lymphocytic Leukemia in 2 studies
Acetaminophen: Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage.
paracetamol : A member of the class of phenols that is 4-aminophenol in which one of the hydrogens attached to the amino group has been replaced by an acetyl group.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hochman, E | 1 |
| Ferenczi, K | 1 |
| Payette, MJ | 1 |
| Bunn, PA | 1 |
| Ihde, DC | 1 |
| Foon, KA | 1 |
2 other studies available for acetaminophen and B-Cell Chronic Lymphocytic Leukemia
| Article | Year |
|---|---|
A peculiar dermatomal plaque.
Topics: Acetaminophen; Aged; Biopsy; Dermatitis; Drug Combinations; Drug Therapy, Combination; Gabapentin; H | 2019 |
Recombinant interferon alfa-2a, an active agent in advanced cutaneous T-cell lymphomas.
Topics: Acetaminophen; Dose-Response Relationship, Drug; Humans; Interferon Type I; Leukemia, Lymphocytic, C | 1987 |